According to multiple recent market analyses, the global API market is experiencing steady growth. One comprehensive forecast ...

New sublingual delivery system designed to enhance bioavailability and speed of onset for major depressive and ...

Halo Pharma's transition to a standalone CDMO allows a concentrated focus on drug product services, enhancing technical ...

Márcio Temtem, Hovione, discusses how his company integrates modular hardware and modeling software to accelerate pharmaceutical R&D and optimize manufacturing processes.

India’s largest drug-maker Sun Pharmaceutical Industries posted a 16 per cent year-on-year (Y-o-Y) growth in its consolidated ...

Aurobindo Pharma Ltd (BOM:524804) reports robust revenue growth driven by European operations and US injectable sales, while ...

In the evolving landscape of pharmaceutical development, modified release (MR) tablets have emerged as a cornerstone technology for improving therapeutic outcomes and patient compliance. Unlike ...

The company is eyeing a revenue of Rs 1,000 crore by 2028 and expects its API plant in Navi Mumbai, which was damaged in a fire in 2025, to resume complete operations by March, Nair tells Moneycontrol ...